Eclipse Therapeutics, Inc. — Form D/A
Eclipse Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2011-10-19. The offering totals $3.0M, of which $2.8M was reported sold. Industry: Other.
Offering
- Filed: 2011-10-19
- Form: D/A
- Accession: 0001532786-11-000003
- Industry: Other
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $2.8M
- Remaining: $225K
- Investors: 20
- Date of first sale: 2011-03-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-167361
Issuer
- Name: Eclipse Therapeutics, Inc.
- CIK: 0001532786
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 5285 FOXBOROUGH POINT, SAN DIEGO, CA, 92130
- Phone: 858-244-7870
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Peter Chu | Director | NEW YORK, NY |
| Jonathan Lim | Director | Thebarton, C3 |
| Christopher Reyes | Director | Miami, FL |
| Peter Chu | Executive Officer | NEW YORK, NY |
| Jonathan Lim | Executive Officer | Thebarton, C3 |
| Christopher Reyes | Executive Officer | Miami, FL |
Other filings by this issuer (1)
More